The Dare to Dream Project

At the heart of our daring mission is a commitment to powering innovative research and introducing safer treatments for pediatric blood cancers. We have already made significant strides by funding the groundbreaking pediatric AML Data Commons—a pioneering platform that ensures consistency in global data reporting. Additionally, our launch of the first-ever acute leukemia LLS PedAL Master Clinical Trial marks a historic step forward, matching patients to treatments based on their cancer's unique tumor biology.

But we're not stopping there. The Dare to Dream Project envisions a future where every child with blood cancer not only survives but thrives. To realize this vision, we are embarking on a mission to raise $175 million over the next five years. These funds will support global collaborative research, the LLS PedAL Master Clinical Trial, and an expansion of our free education, personalized support services, financial assistance, and advocacy efforts on behalf of all children and their families. Join us in daring to dream, as we strive to make a lasting impact on the lives of children battling blood cancers. We're just getting started, and with your support, the possibilities are limitless.